Thomas E. Daley

Empire Biotechnologies, Inc. engages in the development of an orally delivered, therapeutic protein capable of significantly increasing the absorption of nutrients in the intestine. It focuses on treating malabsorption resulting from diseases and syndromes including short bowel syndrome, nectotizing enterocolotis, cystic fibrosis, wasting syndrome, and infant prematurity. The company was founded by Donald McCarthy and Piero Mendez and is headquartered in San Franciso, CA.

Selva Therapeutics, Inc. is a privately held biotechnology company based in San Mateo, CA. Selva Therapeutics is focused on rapidly developing slv213 for COVID-19 and aims to bring a valuable treatment to the market that has the potential to fight multiple life-threatening infectious diseases. Selva Therapeutics, Inc. was founded by Felix Wilhelm Frueh and Thomas E. Daley. The CEO is Thomas E. Daley.